Bridging the gap between science and patient need

The healthcare industry faces a continuous surge in the introduction of newer, technologically superior acting principals and molecules. These advances pose a challenge — and an opportunity — to bring such innovations to market in a way that meaningfully improves outcomes.

Mystic was created to rise to that challenge. Launched in 2019 as a dedicated division under Trigat Life Sciences, Mystic focuses exclusively on speciality and high-science segments where standard formulations leave unmet clinical needs. We identify, develop, and distribute formulations that keep pace with market competition while remaining accessible to all healthcare practitioners.